Related Experiment Video
Updated: Sep 26, 2025

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies
Published on: January 27, 2023
Changes in Serum Liver Function for Patients with COVID-19: A 1-Year Follow-Up Study
Xiaoli Zhu1, Jing Wang1, Juping Du1
1Department of Laboratory Medicine, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, People's Republic of China.
Insights
COVID-19 can cause abnormal liver function that persists for up to one year after hospital discharge. Long-term monitoring of liver function in COVID-19 patients is essential for managing potential long-term health effects.
Area of Science:
- Hepatology
- Infectious Diseases
- Post-COVID Conditions
Background:
- COVID-19 is associated with liver injury during hospitalization.
- Long-term liver function post-discharge in COVID-19 patients remains understudied.
Purpose of the Study:
- To analyze the prevalence and characteristics of abnormal liver function one year after COVID-19 hospital discharge.
- To identify risk factors associated with persistent abnormal liver function.
Main Methods:
- Prospective analysis of serum liver function tests (ALT, AST, ALP, GGT, TB) at multiple time points: hospitalization (T1), pre-discharge (T2), 2 weeks post-discharge (T3), and 1 year post-discharge (T4).
- Definition of abnormal liver function based on exceeding upper limits of reference ranges for key liver enzymes and bilirubin.
- Multivariate logistic regression to identify risk factors for abnormal liver function at one year.
Main Results:
- At one year post-discharge (T4), 28.8% of COVID-19 patients exhibited abnormal liver function.
- The proportion of patients with abnormal liver function increased from 32.2% at T1 to 54.8% at T3, with a decrease to 28.8% at T4.
- Elevated ALT at admission was a significant risk factor (OR=2.041, P=0.012) for abnormal liver function at one year, with GGT and TB elevations being common manifestations.
Conclusions:
- Abnormal liver function can be a persistent condition in COVID-19 survivors, extending up to one year post-discharge.
- Dynamic, long-term monitoring of liver function is crucial for managing COVID-19 patients.
- Admission ALT levels may indicate a higher risk for sustained liver function abnormalities post-COVID-19.
Objective:
Abnormal liver function and liver injury related to COVID-19 during hospitalization has received widespread attention. However, the long-term observation of patients' liver functions after discharge has not been investigated. This study intends to analyze the abnormal liver function in patients one year after they are discharged.
Methods:
Serum liver function tests were analyzed for the first time immediately after hospitalization (T1), before discharge (T2), a median of 14.0 (14.0, 15.0) days after discharge (T3) and 1 year (356.0 (347.8, 367.0) days) after discharge (T4). Patients with at least one serum parameter (ALT, AST, ALP, GGT and TB) exceeding the upper limit of reference range were defined as having abnormal liver function.
Results:
For the 118 COVID-19 patients with a median follow-up time of 376.0 (71.5, 385.3) days from onset to the end of the follow-up after discharge, the proportion with abnormal liver function in T1, T2, T3 and T4 were 32.2%, 45.8%, 54.8% and 28.8%, respectively. The proportion of patients with at least once abnormal liver function detected from T1 to T2, T1 to T3, T1 to T4 was 60.2%, 77.4% and 88.9%, respectively. From T1 to T4, the ALT, AST, GGT and BMI at admission were significantly higher in the patients with persistently abnormal liver function than in the patients with persistently normal liver function. Abnormal liver function was mainly manifested in the elevation of GGT and TB levels. Multivariate logistics regression analysis showed that age and gender-adjusted ALT (odds ratio [OR]=2.041, 95% confidence interval [CI]: 1.170-3.561, P=0.012) at admission was a risk factor for abnormal liver function in the T4 stage.
Conclusion:
Abnormal liver function in patients with COVID-19 can persist from admission to one year after discharge, and therefore, the long-term dynamic monitoring of liver function in patients with COVID-19 is necessary.
More Related Videos
Related Concept Videos
Serum Studies: Renal Function Tests
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

